GNWRX
Price
$31.19
Change
+$0.10 (+0.32%)
Updated
Jun 12 closing price
Net Assets
1.72B
VSMPX
Price
$271.30
Change
+$0.85 (+0.31%)
Updated
Jun 12 closing price
Net Assets
1.82T
Interact to see
Advertisement

GNWRX vs VSMPX

Header iconGNWRX vs VSMPX Comparison
Open Charts GNWRX vs VSMPXBanner chart's image
Nationwide R
Price$31.19
Change+$0.10 (+0.32%)
VolumeN/A
Net Assets1.72B
Vanguard Total Stock Mkt Idx Instl Pls
Price$271.30
Change+$0.85 (+0.31%)
VolumeN/A
Net Assets1.82T
GNWRX vs VSMPX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GNWRX vs. VSMPX commentary
Jun 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GNWRX is a Buy and VSMPX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSMPX has more cash in the bank: 1.82T vs. GNWRX (1.72B). VSMPX pays higher dividends than GNWRX: VSMPX (1.29) vs GNWRX (0.06). GNWRX was incepted earlier than VSMPX: GNWRX (22 years) vs VSMPX (10 years). GNWRX (1.34) is less costly to investors than VSMPX (0.02). GNWRX is a more actively managed with annual turnover of: 83.61 vs. VSMPX (2.00). GNWRX has a lower initial minimum investment than VSMPX: GNWRX (0) vs VSMPX (100000000). VSMPX annual gain was more profitable for investors over the last year : 11.14 vs. GNWRX (-1.18). VSMPX return over 5 years is better than : 93.11 vs. GNWRX (41.59).
GNWRXVSMPXGNWRX / VSMPX
Total Expense Ratio1.300.026,500%
Annual Report Gross Expense Ratio1.340.026,700%
Fund Existence22 years10 years-
Gain YTD2.5732.251114%
Front LoadN/AN/A-
Min. Initial Investment0100000000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.72B1.82T0%
Annual Yield % from dividends0.061.295%
Returns for 1 year-1.1811.14-11%
Returns for 3 years35.6958.4861%
Returns for 5 years41.5993.1145%
Returns for 10 years41.51174.5624%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TAK15.390.22
+1.45%
Takeda Pharmaceutical Company Limited
FELE86.32-0.58
-0.67%
Franklin Electric Co
GPCR22.22-0.50
-2.20%
Structure Therapeutics
GLUE4.92-0.13
-2.57%
Monte Rosa Therapeutics
LTRN3.23-0.15
-4.44%
Lantern Pharma